| Literature DB >> 34176508 |
Rasmus Jørgensen1,2, Christian B Laursen3,4, Lars Konge5,6, Pia Iben Pietersen3,5.
Abstract
BACKGROUND: Placing a peripheral vein catheter can be challenging due to several factors, but using ultrasound as guidance increases the success rate. The purpose of this review is to investigate the knowledge already existing within the field of education in ultrasound-guided peripheral vein catheter placement and explore the efficacy and clinical impact of different types of education.Entities:
Year: 2021 PMID: 34176508 PMCID: PMC8237454 DOI: 10.1186/s13049-021-00897-z
Source DB: PubMed Journal: Scand J Trauma Resusc Emerg Med ISSN: 1757-7241 Impact factor: 2.953
Fig. 1Flowchart of search strategy and selection process based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA)
Scores of the Cochrane tool of Bias
| Selection bias | Performance bias | Detection bias | Attrition bias | Reporting bias | Other bias | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Anything else, ideally pre-specified | ||||
| Bahl [ | Low | Low | / (High) | High | Low | ? / (High) | Low | |||
| Bauman [ | / | / | / (High) | High | Low | High | High | |||
| Breslin [ | / | / | / (High) | High | High | High | Low | |||
| Desai [ | / | / | / (High) | High | Low | High | Low | |||
| Duran-Gehring [ | / | / | / (High) | High | Low | Low | Low | |||
| Feinsmith [ | / | / | / (High) | High | High | High | Low | |||
| Vitto [ | ? (High) | ? (High) | / (High) | High | High | High | High | |||
| Moore [ | / | / | / (High) | High | High | High | High | |||
| Oakley [ | / | / | / (High) | High | Low | High | High | |||
| Bair [ | Low | Low | / (High) | High | Low | Low | Low | |||
| Osborn [ | ? (High) | ? (High) | / (High) | High | Low | High | Low | |||
| Costantino [ | High | / (High) | High | High | High | Low | ||||
| Ault [ | / | / | / (High) | High | High | High | Low | |||
| Fürst [ | / | / | / (High) | High | Low | High | High | |||
| Clemmensen [ | Low | High | / (High) | Low | Low | High | Low | |||
| Blaivas [ | High | High | / (High) | High | Low | High | Low | |||
| Brannam [ | / | / | / (High) | High | High | High | Low | |||
| Carter [ | Low | High | / (High) | High | High | High | Low | |||
| Chinnock [ | / | / | / (High) | High | Low | High | Low | |||
| Davis [ | High | High | / (High) | High | Low | High | High | |||
| Stolz [ | / | / | / (High) | High | High | High | Low | |||
| Durand-Bailloud [ | High | High | / (High) | High | High | High | Low | |||
| Erickson [ | / | / | Low | Low | Low | High | Low | |||
| Griffiths [ | Low | Low | / (High) | High | Low | High | Low | |||
| Oliveira [ | / | / | / (High) | High | High | High | Low | |||
| Jung [ | / | / | / (High) | / | ||||||
| Leung [ | / | / | / (High) | High | High | High | Low | |||
| Tassone [ | Low | High | / (High) | High | Low | Low | Low | |||
| Adhikari [ | / | / | / (High) | ? (High) | ? (High) | High | Low | |||
| Blaivas [ | / | / | / (High) | High | High | High | Low | |||
| Schoenfeld [ | / | / | / (High) | High | Low | High | Low | |||
| Edwards [ | / | / | / (High) | High | High | High | High | |||
| Bridey [ | Low | High | / (High) | High | Low | High | Low | |||
| Good [ | / | / | / (High) | High | High | High | Low | |||
| Sou [ | / | / | / (High) | High | Low | High | Low | |||
| Mahler [ | Low | Low | / (High) | High | Low | High | Low | |||
| Shokoohiet [ | / | / | / (High) | High | High | High | Low | |||
| Costantino [ | High | High | / (High) | High | High | High | High | |||
| Doniger [ | Low | Low | / (High) | High | Low | High | Low | |||
| Panebianco [ | / | / | / (High) | High | High | High | Low | |||
| Maiocco [ | / | / | / (High) | High | High | High | High | |||
| Reeves [ | / | / | / (High) | Low | Low | High | Low | |||
| Primdahl [ | / | / | Low | Low | / | |||||
| Primdahl [ | / | / | / (High) | High | Low | High | Low | |||
| Chenkin [ | Low | Low | / (High) | High | High | Low | Low | |||
| Gopalasingam [ | / | / | / (High) | High | High | Low | Low | |||
| Salleras-Duran [ | / | / | / (High) | High | Low | High | Low | |||
| Stone [ | Low | High | / (High) | High | High | High | High | |||
| Carrie [ | / | / | / (High) | High | Low | High | Low | |||
| Partovi-Deilami [ | / | / | / (High) | High | High | High | High | |||
| Vinograd [ | / | / | / (High) | High | High | High | High | |||
| Dargin [ | / | / | / (High) | High | Low | High | High | |||
/ = not relevant or not possible
? = Unclear
Scores of the Newcastle-Ottawa Scale
| Authors | Study type | Selection | Comparability* | Outcome | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Representativeness of the exposed cohort | Selection of the non exposed cohort | Ascertainment of exposure | Demonstration that outcome of interest was not present at start of study | 1) Study controls for _______ (most important factor) | 1) Study controls for any additional factor | Assessment of outcome | Was follow-up long enough for outcomes to occur? | Adequacy of follow up for cohorts | ||
| Bauman [ | Cohort study | 2(★) | 1(★) | 1(★) | 1(★) | Difficult vein access (★) | / | 3 | 1(★) | 4 |
| Oakley [ | Prospective observational study | 3 | 1(★) | 1(★) | 2 | Difficult vein access (★) | / | 3 | 1(★) | 2(★) |
| Feinsmith [ | Cohort study | 3 | 1(★) | 1(★) | 1(★) | Difficult vein access (★) | / | 2(★) | 1(★) | 2(★) |
| Schoenfeld [ | Prospective observational study | 3 | 3 | 1(★) | 2 | Difficult vein access (★) | / | 2(★) | 1(★) | 2(★) |
| Blaivas [ | Prospective observational study | 2(★) | / | 1(★) | / | / | / | 3 | 1(★) | 2(★) |
| Desai [ | Cross-sectional study | 2(★) | 3 | 1(★) | 1(★) | / | / | 2(★) | 1(★) | 3 |
| Partovi-deilami [ | Cohort study | 3 | 1(★) | 1(★) | 1(★) | On-call access team (★) | / | 2(★) | 1(★) | 2(★) |
| Carrie [ | Cross sectional study | 2(★) | / | 3 | 1(★) | / | / | 2(★) | 1(★) | 1(★) |
| Adhikari [ | Cross sectional study | 2(★) | / | 1(★) | 2 | / | / | 3 | 1(★) | 1(★) |
| Oliveira [ | Cross sectional study | 3 | / | 1(★) | 1(★) | / | / | 3 | 1(★) | 3 |
| Erickson [ | Prospective observational study | 2(★) | 1(★) | 1(★) | 1(★) | / | / | 1(★) | 1(★) | 1(★) |
| Ault [ | Cohort study | 3 | 1(★) | 1(★) | 2 | / | / | 4 | 1(★) | 1(★) |
| Stolz [ | Prospective observational study | 3 | 1(★) | 1(★) | 1(★) | / | / | 2(★) | 1(★) | 1(★) |
| Gopala-singam [ | Cohort study | 3 | 1(★) | 1(★) | 2 | Apheresis patients (★) | / | 1(★) | 1(★) | 1(★) |
| Chinnock [ | Prospective observational study | 4 | / | 1(★) | 2 | / | / | 4 | 1(★) | 1(★) |
| Sou [ | Cohort study | 2(★) | 1(★) | 1(★) | 2 | Difficult vein access (★) | / | 2(★) | 1(★) | 1(★) |
| Good [ | Cohort study | 2(★) | 1(★) | 1(★) | 1(★) | / | / | 2(★) | 1(★) | 1(★) |
| Shokoohi [ | Cohort study | 2(★) | 1(★) | 1(★) | 2 | / | / | 2(★) | 1(★) | 2(★) |
| Panebianco [ | Cohort study | 3 | / | 1(★) | 2 | / | / | 2(★) | 1(★) | 1(★) |
Maiocco [ | Observational study | 3 | 2 | 1(★) | 2 | / | / | 2(★) | 1(★) | 2(★) |
| Reeves [ | Cohort study | 2(★) | ? | 1(★) | 2 | Difficult vein access (★) | / | 2(★) | 1(★) | 4 |
| Salleras-duran [ | Not stated (cross-sections study) | 2(★) | 1(★) | 3 | 2 | / | / | 3 | 1(★) | 1(★) |
| Vinograd [ | Cohort study | 3 | 1(★) | 4 | 2 | / | / | 2(★) | 2 | 3 |
| Dargin [ | Cross sectional study | 1(★) | / | 1(★) | 2 | / | / | 2(★) | 2 | 2(★) |
| Thorn [ | Cohort study | 1(★) | 1(★) | 3 | 2 | / | / | 2(★) | 1(★) | 1(★) |
| Galen [ | Cohort/case control | 1(★) | 1(★) | 1(★) | 1(★) | / | / | 2(★) | 2 | 2(★) |
| Blick [ | Observational study | 2 (★) | / | 1(★) | / | / | / | 3 | 1(★) | 1(★) |
| Anderson [ | Observational study | 1(★) | / | 2(★) | 2 | / | / | 3 | 1(★) | / |
| Batten [ | Cohort study | 3 | 2 | 2(★) | 1(★) | / | No previous Us experience (★) | 2(★) | 1(★) | 1(★) |
| Ballard [ | Cohort study | 1(★) | 1(★) | 1(★) | 1(★) | / | / | 2(★) | 1(★) | 1(★) |
| Amick [ | Prospective cohort study | 2(★) | 1(★) | 2(★) | 1(★) | / | / | 2(★) | 1(★) | 2(★) |
| Bortman [ | Cohort study | 3 | 1(★) | 2(★) | 1(★) | / | / | 4 | 2 | 3 |
| Kaganocskaya [ | Quasiexperimental study (prospective cohort) | 3 | 1(★) | 1(★) | 2 | / | / | 2(★) | 1(★) | 1(★) |
Table 2: Risk of bias assessment Newcastle-Ottawa scale [10]